Search clinical trials for: Glycoside Hydrolase Inhibitors
Total 64268 results
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 1 Diabetes MellitusJapan
-
Seoul National University HospitalUnknownType 2 Diabetes | Endothelial Function | Gemigliptin | AcarboseKorea, Republic of
-
The Hospital for Sick ChildrenTerminatedNon-alcoholic Fatty Liver DiseaseCanada
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedCardiovascular Disease | Insulin Resistance | Pediatric Obesity | Impaired Glucose ToleranceUnited States
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Translational Research Center for Medical Innovation...Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City...CompletedGlucose Metabolism Disorders | Coronary Artery DiseaseJapan
-
The University of Texas Health Science Center at...Completed
-
GWT-TUD GmbHTechnische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...CompletedType 2 Diabetes Mellitus | Subclinical InflammationGermany
-
Indiana University School of MedicineBayerCompleted
-
GWT-TUD GmbHCompleted
-
Oregon State UniversityCompleted
-
Technische Universität DresdenCompleted
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
AgelessRxCompletedTolerance | Side Effect | Glucose ResponseUnited States
-
BayerCompletedDiabetes MellitusRussian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
-
BayerCompletedDiabetes Mellitus, Type 2China
-
University of British ColumbiaCanadian Diabetes AssociationCompletedType 2 Diabetes | Postprandial HypotensionCanada
-
Karolinska InstitutetBayer; The Swedish Research CouncilCompleted
-
Taichung Veterans General HospitalTaipei Veterans General Hospital, Taiwan; Changhua Christian HospitalCompletedDiabetes MellitusTaiwan
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedGlucose Intolerance | Cardiovascular Risk Factor | Postprandial HyperglycemiaMexico
-
BayerCompletedDiabetes MellitusKorea, Republic of
-
BayerCompleted
-
University of Alabama at BirminghamNot yet recruitingKidney CancerUnited States
-
BayerCompleted
-
University of OxfordBayerCompletedCoronary Heart Disease | Acute Coronary Syndrome | Impaired Glucose Tolerance | Type 2 Diabetes Mellitus (T2DM)China, Hong Kong
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2China
-
BayerCompleted
-
Ministry of Science and Technology of the People´s...TakedaUnknownCoronary Heart Disease | Impaired Glucose ToleranceChina
-
BayerCompleted
-
EMSCompletedType 2 Diabetes MellitusBrazil
-
Shanghai Jiao Tong University School of MedicineUnknownType 2 DiabetesChina
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
TakedaCompletedImpaired Glucose ToleranceJapan
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
BayerCompleted
-
Inje UniversitySanofiCompletedDiabetes Mellitus | Type 2 Diabetes MellitusKorea, Republic of
-
Royan InstituteCompletedPCOIran, Islamic Republic of
-
National Cerebral and Cardiovascular CenterMinistry of Health, Labor and Welfare (Japan)TerminatedMyocardial Infarction | Impaired Glucose ToleranceJapan
-
Zhongda HospitalCompletedEfficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus (Match-101)Type 2 Diabetes MellitusChina